問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberALXN1210-IgAN-320
Active

2024-03-15 - 2031-12-31

Phase III

Not yet recruiting1

Recruiting9

ICD-10N05.9

Unspecified nephritic syndrome with unspecified morphologic changes

ICD-10N06.9

Isolated proteinuria with unspecified morphologic lesion

ICD-10N07.9

Hereditary nephropathy, not elsewhere classified with unspecified morphologic lesions

ICD-10N15.9

Renal tubulo-interstitial disease, unspecified

ICD-9583.9

Nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator Yi wen chiu Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Mai-Szu Wu

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Ming-Cheng Wang Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Ming-Ju Wu Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 彭渝森 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator VIN-CENT Wu Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chien-Hsing Wu Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 陳信佑 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Kun-Hua Tu

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Ping-Chin Lai

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    42 participants

  • Global

    470 participants